Wasting no time making her presence felt on the LPGA Tour, Srixon staffer Rio Takeda, delivered a spectacular performance on ...

More than 120 entries have been whittled down to the top 25 women aged under 40 tipped to spearhead the next generation of leading partners.

The "Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been ...

Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Takeda made it rain zebras at a Boston Celtics game Friday. The stunt saw 100 toy zebras parachute from the arena’s rafters ...

Protagonist Therapeutics (NASDAQ:PTGX) and Takeda (NYSE:TAK) said on Monday that its late-stage study of rusfertide for the ...

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 V ...

As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these Tax transparency and international co-operation Enhanced ...

Takeda (TAK) announced that the EMA has approved an additional two mL pre-filled pen option for Takhzyro for subcutaneous administration in adolescents and adult patients with Hereditary ...

EXCLUSIVE: Former Disney/Pixar veteran Michael Agulnek has joined Sony Pictures as EVP Global Publicity, where he will report to Danielle Misher, Co-Head of Theatrical Marketing. In addition ...